These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 36062048)

  • 1. Heterotopic Transcatheter Tricuspid Valve Replacement in Severe Tricuspid Regurgitation and Refractory Right Heart Failure.
    Costa G; De Carlo M; Spontoni P; Giannini C; Angelillis M; Stazzoni L; Bozzoli D; Del Sorbo R; Petronio AS
    JACC Case Rep; 2022 Aug; 4(16):1005-1011. PubMed ID: 36062048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcatheter Caval Valve Implantation of the Tricento Valve for Tricuspid Regurgitation Using Advanced Intraprocedural Imaging.
    Werner P; Russo M; Scherzer S; Aref T; Coti I; Mascherbauer J; Kocher A; Laufer G; Andreas M
    JACC Case Rep; 2019 Dec; 1(5):720-724. PubMed ID: 34316918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Experimental and Computational Study on the Effect of Caval Valved Stent Oversizing.
    Ismail M; Kumar GP; Kabinejadian F; Nguyen YN; Cui F; Tay EL; Leo HL
    Cardiovasc Eng Technol; 2016 Sep; 7(3):254-69. PubMed ID: 27357300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterotopic transcatheter tricuspid valve implantation: first-in-man application of a novel approach to tricuspid regurgitation.
    Lauten A; Ferrari M; Hekmat K; Pfeifer R; Dannberg G; Ragoschke-Schumm A; Figulla HR
    Eur Heart J; 2011 May; 32(10):1207-13. PubMed ID: 21300731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study design and rationale of the heterotopic implantation of the Edwards-Sapien XT transcatheter valve in the inferior VEna cava for the treatment of severe tricuspid regurgitation (HOVER) trial.
    O'Neill BP; Wheatley G; Bashir R; Edmundowicz D; O'Murchu B; O'Neill WW; Patil P; Chen A; Forfia P; Cohen HA
    Catheter Cardiovasc Interv; 2016 Aug; 88(2):287-93. PubMed ID: 27122473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vitro Investigation of the Hemodynamics of Transcatheter Heterotopic Valves Implantation in the Cavo-Atrial Junction.
    Ismail M; Kabinejadian F; Nguyen YN; Tay E; Kim S; Leo HL
    Artif Organs; 2015 Sep; 39(9):803-14. PubMed ID: 25920812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcatheter Caval Valve Implantation for Tricuspid Regurgitation After Single Leaflet Device Attachment.
    Rroku A; Barbieri F; Landmesser U; Skurk C; Kasner M; Reinthaler M
    JACC Case Rep; 2022 Apr; 4(8):481-485. PubMed ID: 35493801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterotopic caval valve implantation in severe tricuspid regurgitation.
    Sharma NK; Chouhan NS; Bansal M; Chandra P; Singh A; Juneja R; Mehta Y; Trehan N
    Ann Card Anaesth; 2021; 24(3):365-368. PubMed ID: 34269270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interventional Treatment of Severe Tricuspid Regurgitation: Early Clinical Experience in a Multicenter, Observational, First-in-Man Study.
    Lauten A; Figulla HR; Unbehaun A; Fam N; Schofer J; Doenst T; Hausleiter J; Franz M; Jung C; Dreger H; Leistner D; Alushi B; Stundl A; Landmesser U; Falk V; Stangl K; Laule M
    Circ Cardiovasc Interv; 2018 Feb; 11(2):e006061. PubMed ID: 29445001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomechanical performance of the Bicaval Transcatheter System for the treatment of severe tricuspid regurgitation.
    Crascì F; Cannata S; Gentile G; Gandolfo C; Pasta S
    Front Bioeng Biotechnol; 2023; 11():1179774. PubMed ID: 37274165
    [No Abstract]   [Full Text] [Related]  

  • 11. Intermediate term hemodynamic effects of single inferior vena cava valve implant for the treatment of severe tricuspid regurgitation.
    Rakita V; Lakhter V; Patil P; O'Neill BP
    Catheter Cardiovasc Interv; 2017 Sep; 90(3):521-525. PubMed ID: 28168785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous Inferior Vena Cava Valve Implantation May Improve Tricuspid Valve Regurgitation and Cardiac Output: Lessons Learned.
    Aalaei-Andabili SH; Bavry AA; Choi C; Arnaoutakis G; Anderson RD; Beaver TM
    Innovations (Phila); 2020; 15(6):577-580. PubMed ID: 33104457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computed tomography for planning transcatheter tricuspid valve therapy.
    van Rosendael PJ; Kamperidis V; Kong WK; van Rosendael AR; van der Kley F; Ajmone Marsan N; Delgado V; Bax JJ
    Eur Heart J; 2017 Mar; 38(9):665-674. PubMed ID: 27807057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early Single-Site Experience With Transcatheter Tricuspid Valve Replacement.
    Hahn RT; George I; Kodali SK; Nazif T; Khalique OK; Akkoc D; Kantor A; Vahl TP; Patel A; Elias E; Ng V; Spina R; Bartus K; Velagapudi P; Wu I; Leon M; Bapat V
    JACC Cardiovasc Imaging; 2019 Mar; 12(3):416-429. PubMed ID: 30553658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterotopic Transcatheter Tricuspid Valve Replacement in a Patient With Carcinoid Heart Disease.
    Stolz L; Doldi PM; Weckbach LT; Schwinger RHG; Stocker TJ; Massberg S; Näbauer M; Hausleiter J
    JACC Case Rep; 2022 Dec; 4(23):101679. PubMed ID: 36438434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterotopic caval valve implantation for the management of severe tricuspid regurgitation: a case series.
    Sharkey A; Munoz Acuna R; Belani K; Sharma RK; Chaudhary O; Fatima H; Laham R; Mahmood F
    Eur Heart J Case Rep; 2021 Jan; 5(1):ytaa428. PubMed ID: 33644639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of tricuspid regurgitation and the right heart on survival after transcatheter aortic valve replacement: insights from the Placement of Aortic Transcatheter Valves II inoperable cohort.
    Lindman BR; Maniar HS; Jaber WA; Lerakis S; Mack MJ; Suri RM; Thourani VH; Babaliaros V; Kereiakes DJ; Whisenant B; Miller DC; Tuzcu EM; Svensson LG; Xu K; Doshi D; Leon MB; Zajarias A
    Circ Cardiovasc Interv; 2015 Apr; 8(4):. PubMed ID: 25855679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caval Valve Implantation for Tricuspid Regurgitation: Insights From the United States Caval Valve Registry.
    O'Neill BP; Negrotto S; Yu D; Lakhter V; Depta J; McCabe JM; Dube S; Vaikom M; Wang DD; Patil P; Lindman B; Iglessis-Azuaje I; Fredi J; Lu X; O'Neill WW
    J Invasive Cardiol; 2020 Dec; 32(12):470-475. PubMed ID: 33087585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of inferior vena cava entry characteristics on tricuspid annular access during transcatheter interventions.
    Ranard LS; Vahl TP; Chung CJ; Sadri S; Khalique OK; Hamid N; Nazif T; George I; Ng V; Patel A; Rezende CP; Reisman M; Latib A; Hausleiter J; Sorajja P; Bapat VN; Tang GHL; Davidson CJ; Zahr F; Makkar R; Fam NP; Granada JF; Leon MB; Hahn RT; Kodali S
    Catheter Cardiovasc Interv; 2022 Mar; 99(4):1268-1276. PubMed ID: 35084803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal fluoroscopic viewing angles of right-sided heart structures in patients with tricuspid regurgitation based on multislice computed tomography.
    Xiong TY; Pighi M; Thériault-Lauzier P; Leipsic J; Spaziano M; Martucci GJ; Buithieu J; Mousavi N; Pilgrim T; Praz F; Windecker S; Chen M; Piazza N
    EuroIntervention; 2019 Nov; 15(10):. PubMed ID: 31746757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.